Expert consensus on the management of hypertension in the young and middle-aged Chinese population

Jing Liu; Xinzheng Lu; Luyuan Chen; Yong Huo

doi:10.1111/ijcp.13426

Expert consensus on the management of hypertension in the young and middle-aged Chinese population

Int J Clin Pract. 2019 Oct 1:e13426. doi: 10.1111/ijcp.13426. Online ahead of print.

Authors

Jing Liu¹, Xinzheng Lu², Luyuan Chen³, Yong Huo¹

Affiliations

¹ Peking University People's Hospital Ringgold standard institution, Department of Cardiology, Beijing, China.
² The First Affiliated Hospital of Nanjing Medical University, Department of Cardiology, Nanjing, China.
³ Guangdong General Hospital Ringgold standard institution, Deparment of Cardiology, Guangzhou, China.

PMID: 31573725
DOI: 10.1111/ijcp.13426

Abstract

Hypertension, defined as blood pressure (BP) ≥140/90 mmHg, is one of the most common, yet reversible, risk factors for cardiovascular disease (CVD). Globally, 9.40 million people died from hypertension in 2010, accounting for 17.8% of total deaths; disability-adjusted life years (DALYs) caused by hypertension were 170 million person-years, or 7.0% of the total global DALYs.¹ Data from China showed that hypertension accounted for 24.6% of all deaths, and 12.0% of total DALYs,² and the direct medical cost of hypertension in China has reached 36.6 billion yuan per year.³.